Monopar Therapeutics Inc.
NASDAQMonopar Therapeutics has surged 30% in a single week — yet short interest remains near 24% of float and the lending pool is close to fully squeezed, making the tension between bulls and bears unusually charged. The borrow market tells the most interesting part of this week's story. Availability has been deeply crimped for most of June, dropping as low as 2.5% on June 16 before a…
Snapshot as of 28 Jun 2026
Monopar Therapeutics has surged 30% in a single week — yet short interest remains near 24% of float and the lending pool is close to fully squeezed, making the tension between bulls and bears unusually charged. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MNPR — free to start on ORTEX.
Sign up for free →Open MNPR on ORTEX